Get started
Author

S Avery

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome
2014 · P Tan, A Wei, et al. · Blood Cancer Journal · 94
PDF
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma
2004 · E Terpos, M Politou, et al. · Leukemia · 66
The successful treatment of primary cardiac lymphoma with a dose-dense schedule of rituximab plus CHOP
2005 · M.A. Dawson, J. Mariani, et al. · Annals of Oncology · 36
PDF
Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinib
2004 · S Avery, E Nadal, et al. · Leukemia Research · 18
Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation
2011 · S Avery, M H Voss, et al. · Bone Marrow Transplantation · 15
Allo-SCT for hematological malignancies in the setting of HIV
2009 · M N Polizzotto, M Skinner, et al. · Bone Marrow Transplantation · 15
Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
2014 · P Campbell, P Walker, et al. · Blood Cancer Journal · 14
PDF
Blood transfusion requirements for patients undergoing chemotherapy for acute myeloid leukemia how much is enough?
2007 · M. A. Dawson, S. Avery, et al. · Haematologica · 14
PDF
Oral chronic graft‐versus‐host disease in A ustralia: clinical features and challenges in management
2015 · K. Hull, I. Kerridge, et al. · Internal Medicine Journal · 13
PDF
High‐dose cytarabine (24 g/m2) in combination with idarubicin ( HiDAC ‐3) results in high first‐cycle response with limited gastrointestinal toxicity in adult acute myeloid leukaemia
2012 · M. Low, D. Lee, et al. · Internal Medicine Journal · 10
Health economic impact of high‐dose versus standard‐dose cytarabine induction chemotherapy for acute myeloid leukaemia
2014 · P. L. Fedele, S. Avery, et al. · Internal Medicine Journal · 8
Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation
2015 · E Viner Smith, A C Tierney, et al. · Bone Marrow Transplantation · 7
Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma
2017 · A P Nair, P Walker, et al. · Bone Marrow Transplantation · 6
Factors associated with post-traumatic stress symptoms experienced in the acute phase following haemopoietic stem cell transplant
2015 · B Pillay, S J Lee, et al. · Bone Marrow Transplantation · 5
Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: eighty-month follow-up
2009 · S Patil, A Spencer, et al. · Bone Marrow Transplantation · 4
Failure of haematopoietic recovery overcome by SCT despite invasive mucormycosis infection
2011 · G Grigoriadis, C C Chang, et al. · Bone Marrow Transplantation · 1
PT04.5: Delayed Initiation of Nutrition Support is Associated with More Severe Weight Loss Following Haemopoietic Stem Cell Transplant
2016 · S. King, S. Avery, et al. · Clinical Nutrition
MON-PP080: Weight Loss Following Allogeneic Stem Cell Transplant Peaks at Four Months and is not Regained after One Year
2015 · S. King, S. Avery, et al. · Clinical Nutrition
Total Donor Chimerism in the Day 21 Bone Marrow Predicts Sustained Donor Neutrophil Engraftment Following Double Unit Cord Blood Transplantation (CBT)
2011 · S. Avery, M.H. Voss, et al. · Transplantation and Cellular Therapy
PDF
Works count: 19
Citation count: 326
H-index: 10
I10-index: 10
Year
Topic
Type